The goal of this observational study is to evaluate the safety and effectiveness of a home-monitoring device (RespirAI) in the early detection of COPD exacerbations in adults (age \>21) with physician-diagnosed COPD who are at high risk for exacerbations. The study will collect data from participants with COPD that will be analyzed using an AI-based algorithm to predict exacerbation events. The device's predictions will then be compared against clinically documented exacerbations to assess detection accuracy.
Study Type
OBSERVATIONAL
Enrollment
30
Use of a software-based monitoring device for 6 months.
Methodist Physicians Clinic
Omaha, Nebraska, United States
RECRUITINGSensitivity
Percentage of clinically verified moderate or severe COPD exacerbation events detected by the device
Time frame: 6 months
False alam rate
The rate of false alarms produced by the device.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.